MARKET

AQST

AQST

Aquestive Therapeutics
NASDAQ
2.235
-0.055
-2.40%
Opening 14:56 05/14 EDT
OPEN
2.350
PREV CLOSE
2.290
HIGH
2.410
LOW
2.155
VOLUME
1.86M
TURNOVER
--
52 WEEK HIGH
5.80
52 WEEK LOW
2.120
MARKET CAP
221.98M
P/E (TTM)
-4.3918
1D
5D
1M
3M
1Y
5Y
1D
Lake Street Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST)
TipRanks · 5h ago
Analysts Offer Insights on Healthcare Companies: Astria Therapeutics (ATXS), Aquestive Therapeutics (AQST) and Olema Pharmaceuticals (OLMA)
TipRanks · 7h ago
AQUESTIVE THERAPEUTICS INC <AQST.O>: LEERINK PARTNERS CUTS TARGET PRICE TO $10 FROM $12
Reuters · 7h ago
U.S. RESEARCH ROUNDUP-Fair Issac, First Solar, UnitedHealth
Reuters · 11h ago
Aquestive Therapeutics’ Q1 2025: Focus on Anaphylm
TipRanks · 14h ago
Aquestive Therapeutics price target lowered to $5 from $8 at Piper Sandler
TipRanks · 1d ago
Tuesday Sector Laggards: Water Utilities, Drugs
NASDAQ · 1d ago
Aquestive Therapeutics' Shares Fall to 52-Week Low on 1Q Results, Outlook Cut
Dow Jones · 1d ago
More
About AQST
More
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in developing orally administered and topical gel products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies. It has four commercialized products marketed by the Company’s licensees in the United States and around the world and is the manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary technologies, including PharmFilm, and has proven drug development and commercialization capabilities. The Company is advancing a late-stage proprietary product candidate for the treatment of severe allergic reactions, including anaphylaxis, and an early-stage epinephrine prodrug topical gel product candidate for various possible dermatology conditions. Its portfolio includes Anaphylm, AQST-108, Libervant, Suboxone, and Emylif.
Recently
Symbol
Price
%Change

Webull offers Aquestive Therapeutics Inc stock information, including NASDAQ: AQST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AQST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AQST stock methods without spending real money on the virtual paper trading platform.